WKN DE: A41X7J / ISIN: US98386D4060

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Xtl Biopharmaceuticals Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
19:18:52	2,080
19:04:59	2,060
17:32:48	1,980
17:18:36	1,980
17:03:45	1,980
16:50:12	1,980
16:18:21	2,060
15:49:36	2,080
15:33:27	2,120
15:18:31	2,060
15:03:08	2,060
14:48:15	2,060
14:33:11	2,060
14:18:29	2,060
13:47:54	2,060
13:32:21	2,060
13:17:58	2,060
13:03:35	2,060
12:49:26	2,060
12:46:23	2,060
12:31:50	2,060
12:16:33	2,060
12:01:32	2,060
11:46:20	2,060
11:31:20	2,060
11:16:21	2,060
11:01:25	2,060
10:46:14	2,060
10:31:12	2,060
10:20:07	2,060
10:16:07	2,060
10:01:08	2,060

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Xtl Biopharmaceuticals Ltd (spons. ADRs)

Weitere Meldungen

18:59		Dick’s Sporting Goods’ epic drop hits other footwear giants, as shoppers sour on retro sneakers
18:50		Is Borr Drilling a Buy After Director Tor Olav Troim Buys 200,000 More Shares?
18:49		Nomad Foods CFO Baldew Buys 28,290 Shares at $11.85 -- Should Investors Be Buying Too?
18:42		Why Sandisk Stock Popped, Then Dropped Today
18:39		Western Digital vs. Seagate Technology: Which Data Storage Stock Is the Better Buy?
18:32		‘It’s the ultimate regifting’: My mom gave me a house. Should I transfer it back to her to reduce capital gains?
18:22		Alpha Metallurgical Resources Director Courtis Buys Again, This Time $3.2 Million in Shares. Is it Time for Investors to Buy Too?
18:20		If I Could Tell Every S&P 500 Investor Just 1 Thing About the Stock Market Right Now, It's This.
18:19		E.P.A. Moves to Curb Public Input on Air Pollution Permits for Data Centers
18:16		QUICK SPARK: Nvidia-Backed Biotech Says AI Could Make Biology Programmable
18:15		Here's How Much $1000 Invested In Ares Management 10 Years Ago Would Be Worth Today
18:15		Should You Invest in the Vanguard Total World Stock ETF? Here's My Honest Take.
18:14		Why Is Robinhood Stock Surging on Tuesday?
18:08		ROG Xbox Ally X20: OLED-Upgrade mit deutlichem Preisaufschlag
18:05		SpaceX Is Building a $16.8 Billion Chip Fab in Texas. Is This a Genius Move or a Red Flag For Investors?
18:04		These growth stocks are still cheap, despite the S&P 500 being near a record high price-to-sales valuation
18:02		Einhorn Vs. Musk: Hedge Fund Manager Says SpaceX IPO Was ‘Meme-ification of the Market’
18:00		Here’s How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
18:00		Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off
17:57		Scott Bessent's Bond Plan 'Won't Work,' Citi Economist Says: US Fiscal Position Is 'Absolutely Out of Control'
17:57		EXCLUSIVE: Nvidia's Biggest Contribution to AI Drug Discovery Isn't Money, Generate CTO Says
17:57		Kura Oncology CEO Buys 100,000 Shares for $1.2 Million. Does This Large Buy Bode Well for Shares in 2026?
17:54		Why Marvell Technology Stock Is Rocketing Higher Today
17:53		Klarna (KLAR) Q2 2026 Earnings Call Transcript
17:53		Amer Sports (AS) Q2 2026 Earnings Call Transcript
17:53		Waymo kündigt Betrieb in München an
17:49		This Five Below Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
17:45		Salesforce Q2: AI Is Growing Fast, CRM Needs New Customers To Catch Up
17:45		Here’s How Much You Would Have Made Owning KLA Stock In The Last 10 Years
17:45		If I Could Tell All Investors 1 Thing About Buying at Record Highs, It Would Be This
17:44		What's Going On With Dell Technologies Stock Tuesday?
17:36		Nutanix Is Selling Plenty of Software. Growth May Cool as Hardware Stays Tight
17:31		Novavax Stock Rallies Tuesday: What's Happening?
17:31		McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
17:31		Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today
17:30		Dell Technologies vs. UiPath: Which Technology Stock Is a Better Buy in 2026?
17:25		What's Going On With CoreWeave Stock Tuesday?
17:24		Browser-Tracking per Web Audio: Das verborgene Tonstudio
17:21		Palantir's Maven Is Now an Official Pentagon Program of Record. Here's What Guaranteed Budget Dollars Are Worth.
17:15		Here's How Much $1000 Invested In Ameriprise Financial 5 Years Ago Would Be Worth Today
17:15		Netflix Stock Is Down Big-Time. Is This Finally a Buying Opportunity?
17:14		Synopsys Q3 Preview: 40% Revenue Growth On AI Products, Ansys Acquisition
17:11		Accenture Buys McCoy To Accelerate Midmarket AI Expansion
17:08		Shipbuilder Penguin International wins first prime contract with Singapore Navy
17:07		Dick's Sporting Goods Stock Plunges 25% on $31.9M Foot Locker Investment Loss
17:04		Intuit Stock Falls Ahead of Q4 Earnings: What Investors Need to Know
17:04		What Nvidia says on Wednesday to address concerns about its competitiveness could be key for the stock
17:03		Nebius Group N.V. vs. SoundHound AI: Which AI Stock Will Bring You Profits in 2026 and Beyond?
17:02		Trump’s Canada Tariffs Rely on Untested Law
17:02		Humanoid Robots Could Match Humans Within 5 Years, RoboStrategy CEO Says

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Jacktel AS Registered Shs Esentia Energy Development SAB de CV Registered Shs Series -II- Unitary Muyuan Foods XORTX Therapeutics BibbInstruments AB Registered Shs Issue 2026

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	25.08.2026 19:22
Kaufwert:	EUR
	Hinzufügen Speichern

Xtl Biopharmaceuticals Aktie

WKN DE: A41X7J / ISIN: US98386D4060

Xtl Biopharmaceuticals Times and Sales (STU)

Analysen zu Xtl Biopharmaceuticals Ltd (spons. ADRs)

Weitere Meldungen